Literature DB >> 9716310

Evidence for 5-HT1A receptor control of pineal melatonin concentrations in the rat.

P J Nathan1, G D Burrows, T R Norman.   

Abstract

The effect of some serotonin agonists on day and night-time melatonin in the pineal gland was investigated in male rats. Dose dependent increases in nocturnal melatonin concentrations were observed for all serotonin agonists investigated. Statistically significant increases were observed only for D-fenfluramine (20 mg/kg) and the full 5-HT1A agonists S(+)-20499 (10 mg/kg, 20 mg/kg) and flesinoxan (20 mg/kg). Both paroxetine and D-fenfluramine dose dependently increased day-time pineal melatonin, but only for D-fenfluramine (20 mg/kg) was there a statistically significant increase. The data suggest that acute increases in synaptic serotonin concentrations can be used to manipulate day- or night-time melatonin. Data suggests an influence of the 5-HT1A receptor subtype in mediating nocturnal melatonin concentrations, perhaps through a functional coupling to beta1-adrenoceptors on the pineal gland.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716310     DOI: 10.1016/s0924-977x(97)00060-6

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  2 in total

1.  Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's disease.

Authors:  Laurence Mignon; William A Wolf
Journal:  Psychopharmacology (Berl)       Date:  2007-01-31       Impact factor: 4.415

2.  Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons.

Authors:  Emily A Karanges; Mohammed A Kashem; Ranjana Sarker; Eakhlas U Ahmed; Selina Ahmed; Petra S Van Nieuwenhuijzen; Andrew H Kemp; Iain S McGregor
Journal:  Front Pharmacol       Date:  2013-07-08       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.